Orient Paper Q1 FY27: standalone loss narrows to ₹8.3 Cr, adjusted YoY improves ~43%

Orient Paper & Industries reported a standalone net loss of ₹8.25 Cr for Q1 FY27 (quarter ended June 30, 2026), on revenue from operations of ₹227.6 Cr, down 4.5% YoY (₹238.3 Cr) and 1.7% QoQ (₹231.5 Cr). Read on a raw basis, the bottom line appears to swing from a ₹34.0 Cr profit a year ago into this quarter's loss — but that comparison is misleading. The Q1 FY26 result carried a one-off ₹48.49 Cr deferred-tax credit from the company's Section 115BAA tax-rate re-measurement (disclosed in note 3 of the results), without which Q1 FY26 was itself a loss of roughly ₹14.5 Cr. Adjusted for that one-off, the underlying loss narrowed by about 43% YoY, and by 24.6% sequentially versus Q4 FY26's ₹10.94 Cr loss. The improvement is visible in the operating line: OPM (EBITDA/revenue) expanded to about 3.5% from 0.6% a year ago and 1.6% last quarter, helped by finance costs falling 18.7% YoY to ₹6.59 Cr (₹8.11 Cr in Q1 FY26) and power & fuel costs easing to ₹51.7 Cr from ₹54.9 Cr YoY, even as they ticked up from ₹49.6 Cr in Q4 FY26. By segment, the paper & tissue business — the larger and structurally weaker of the two — cut its segment loss to ₹4.21 Cr from ₹9.35 Cr YoY and ₹8.40 Cr QoQ, while the chemicals segment grew profit to ₹6.10 Cr from ₹5.97 Cr YoY and ₹4.00 Cr QoQ. Net profit margin stayed negative at -3.6%, still worse optically than the year-ago quarter's reported +14.1%, but that YoY margin comparison is entirely an artifact of the one-off tax credit rather than a genuine deterioration. The company has not put any formal revenue or margin guidance on record in our tracked history, and no prior concall commentary is available to check this print against; a web search for Street/analyst previews specific to this quarter also turned up nothing concrete for this small-cap name, so vsGuidance and vsStreet are both marked unknown rather than assumed. Orient Paper did not issue a separate press release alongside this filing — the only management commentary is the regulatory board-outcome letter, which contains no financial framing beyond the numbers themselves. Alongside the results, the board approved Anuradha Mookerjee's appointment as an independent director (effective August 8, 2026) and noted Gauri Rasgotra's retirement from the board (effective August 21, 2026); neither is financially material to the quarter. A new COO was also appointed in late June 2026, just before this quarter closed, so its operational impact — if any — will only show up from Q2 FY27 onward.